# Induction Chemotherapy Followed by IMRT or Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma

> **NCT05527470** · PHASE3 · RECRUITING · sponsor: **Wei Jiang** · enrollment: 440 (estimated)

## Conditions studied

- Nasopharyngeal Carcinoma

## Interventions

- **DRUG:** Gemcitabine,Cisplatin
- **RADIATION:** Intensity-modulated radiation therapy (IMRT)
- **DRUG:** Cisplatin

## Key facts

- **NCT ID:** NCT05527470
- **Lead sponsor:** Wei Jiang
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-11-11
- **Primary completion:** 2025-11-11
- **Final completion:** 2027-11-11
- **Target enrollment:** 440 (ESTIMATED)
- **Last updated:** 2023-05-03

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05527470

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05527470, "Induction Chemotherapy Followed by IMRT or Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma". Retrieved via AI Analytics 2026-07-28 from https://api.ai-analytics.org/clinical/NCT05527470. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*